Evidence map›Paper›PMID 34654371›Full record

ReviewJournal of neurodevelopmental disorders2021

Pre-symptomatic intervention for autism spectrum disorder (ASD): defining a research agenda.

Rebecca Grzadzinski, Dima Amso, Rebecca Landa, Linda Watson, Michael Guralnick, Lonnie Zwaigenbaum, Gedeon Deák, Annette Estes, Jessica Brian, Kevin Bath and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of neurodevelopmental disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 2 countries.

Rebecca GrzadzinskiCarolina Institute for Developmental Disabilities, University of North Carolina, Chapel Hill, NC, USA. Rebecca_grzadzinski@med.unc.edu.ORCID 0000-0001-7764-6166
Dima AmsoDepartment of Psychology, Columbia University, New York, NY, USA.
Rebecca LandaCenter for Autism and Related Disorders, Kennedy Krieger Institute, Baltimore, MD, USA.
Linda WatsonProgram for Early Autism Research Leadership and Service (PEARLS), University of North Carolina, Chapel Hill, NC, USA.
Michael GuralnickCenter on Human Development and Disability, University of Washington, Seattle, WA, USA.
Lonnie ZwaigenbaumDepartment of Pediatrics, University of Alberta, Edmonton, Canada.
Gedeon DeákDepartment of Cognitive Science, University of California, San Diego, San Diego, CA, USA.
Annette EstesDepartment of Speech and Hearing Sciences, University of Washington Autism Center, University of Washington, Seattle, WA, USA.
Jessica BrianHolland Bloorview Kids Rehabilitation Hospital, Toronto, Canada.
Kevin BathDepartment of Neuroscience, Brown University, Providence, RI, USA.
Jed ElisonInstitute of Child Development, University of Minnesota, Minneapolis, MN, USA.
Leonard AbbedutoUniversity of California, Davis, MIND Institute, University of California, Davis, Sacramento, CA, USA.
Jason Wolff *Department of Educational Psychology, University of Minnesota, Minneapolis, MN, USA.
Joseph Piven *Carolina Institute for Developmental Disabilities, University of North Carolina, Chapel Hill, NC, USA.
University of North Carolina at Chapel Hill · USUniversity of Minnesota · USUniversity of Washington · USBrown University · USColumbia University · USKennedy Krieger Institute · USUniversity of Alberta · CAUniversity of California, Davis · USUniversity of California San Diego · USUniversity of Toronto · CA

Funding

North Carolina Translational and Clinical Science Institute (NC TraCS) KL2KL2TR002490 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WEINBERGER, MORRIS · 2018 to 2022
$11.0M
Mechanisms of Brain Dysmorphology in MN1 C-Terminal Truncation Syndrome, a Novel Intellectual Developmental Disability Disorder P50HD103524 · NICHD · UNIVERSITY OF WASHINGTON · PI DANIEL DOHERTY · 2020 to 2026
$9.9M
Preclinical CoreP50HD103573 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GABRIEL S DICHTER · 2020 to 2026
$9.7M
Research Project: Pathologic Significance of Maternal AutoantibodiesP50HD103526 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEONARD J. ABBEDUTO, Melissa Dawn Bauman · 2020 to 2026
$9.7M
Postdoctoral Research in Neurodevelopmental DisordersT32HD040127 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BENJAMIN D PHILPOT, Mark D Shen · 2001 to 2026
$8.5M
Development and neural mechanisms of repetitive behavior and sensory responsivity in autismR01MH116961 · NIMH · UNIVERSITY OF MINNESOTA · PI WOLFF, JASON J · 2018 to 2022
$2.8M
NCATS NIH HHS KL2 TR002490NICHD NIH HHS P50 HD103524NICHD NIH HHS P50 HD103573NICHD NIH HHS T32 HD040127NIMH NIH HHS R01 MH116961
6 · The paper itself

Abstract

Autism spectrum disorder (ASD) impacts an individual's ability to socialize, communicate, and interact with, and adapt to, the environment. Over the last two decades, research has focused on early identification of ASD with significant progress being made in understanding the early behavioral and biological markers that precede a diagnosis, providing a catalyst for pre-symptomatic identification and intervention. Evidence from preclinical trials suggest that intervention prior to the onset of ASD symptoms may yield more improved developmental outcomes, and clinical studies suggest that the earlier intervention is administered, the better the outcomes. This article brings together a multidisciplinary group of experts to develop a conceptual framework for behavioral intervention, during the pre-symptomatic period prior to the consolidation of symptoms into diagnosis, in infants at very-high-likelihood for developing ASD (VHL-ASD). The overarching goals of this paper are to promote the development of new intervention approaches, empirical research, and policy efforts aimed at VHL-ASD infants during the pre-symptomatic period (i.e., prior to the consolidation of the defining features of ASD).

Indexed as

Autism Spectrum DisorderBehavior TherapyHumansInfantSocial Behavior

Identifiers

PMID34654371
PMCPMC8520312
OpenAlexW3205598152

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.